Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1081 to 1088 of 1088 entries
Sorted by: Best Match Show Resources per page
CADASIL and Cavernomas: A Common Mechanism.

Annals of Indian Academy of Neurology

Pedapati R, Vishnu VY, Singh MB, Goyal V, Garg A, Srivastava P.
PMID: 33223688
Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):570-572. doi: 10.4103/aian.AIAN_684_19. Epub 2020 Jul 16.

No abstract available.

Cite
Pedapati R, Vishnu VY, Singh MB, et al. CADASIL and Cavernomas: A Common Mechanism. Ann Indian Acad Neurol. 2020;23(4):570-572doi: 10.4103/aian.AIAN_684_19.
Pedapati, R., Vishnu, V. Y., Singh, M. B., Goyal, V., Garg, A., & Srivastava, P. (2020). CADASIL and Cavernomas: A Common Mechanism. Annals of Indian Academy of Neurology, 23(4), 570-572. https://doi.org/10.4103/aian.AIAN_684_19
Pedapati, Radhakrishna, et al. "CADASIL and Cavernomas: A Common Mechanism." Annals of Indian Academy of Neurology vol. 23,4 (2020): 570-572. doi: https://doi.org/10.4103/aian.AIAN_684_19
Pedapati R, Vishnu VY, Singh MB, Goyal V, Garg A, Srivastava P. CADASIL and Cavernomas: A Common Mechanism. Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):570-572. doi: 10.4103/aian.AIAN_684_19. Epub 2020 Jul 16. PMID: 33223688; PMCID: PMC7657275.
Copy Download .nbib Format: NLM
Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Garg A, Dhanesha N, Shaban A, Samaniego EA, Chauhan AK, Leira EC.
PMID: 34500199
J Stroke Cerebrovasc Dis. 2021 Nov;30(11):106077. doi: 10.1016/j.jstrokecerebrovasdis.2021.106077. Epub 2021 Sep 06.

BACKGROUND: The mechanism of increased risk of venous thromboembolism (VTE) after acute ischemic stroke (AIS) is unclear. In this study, we aimed to evaluate the risk of VTE in hospitalizations due to AIS as compared to those due to...

Cite
Garg A, Dhanesha N, Shaban A, et al. Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions. J Stroke Cerebrovasc Dis. 2021;30(11):106077doi: 10.1016/j.jstrokecerebrovasdis.2021.106077.
Garg, A., Dhanesha, N., Shaban, A., Samaniego, E. A., Chauhan, A. K., & Leira, E. C. (2021). Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 30(11), 106077. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106077
Garg, Aayushi, et al. "Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 30,11 (2021): 106077. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106077
Garg A, Dhanesha N, Shaban A, Samaniego EA, Chauhan AK, Leira EC. Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions. J Stroke Cerebrovasc Dis. 2021 Nov;30(11):106077. doi: 10.1016/j.jstrokecerebrovasdis.2021.106077. Epub 2021 Sep 06. PMID: 34500199.
Copy Download .nbib Format: NLM
Inherited Manganese Disorders and the Brain: What Neurologists Need to Know.

Annals of Indian Academy of Neurology

Kapoor D, Garg D, Sharma S, Goyal V.
PMID: 33911374
Ann Indian Acad Neurol. 2021 Jan-Feb;24(1):15-21. doi: 10.4103/aian.AIAN_789_20. Epub 2021 Feb 05.

Although acquired manganese neurotoxicity has been widely reported since its first description in 1837 and is popularly referred to as "manganism," inherited disorders of manganese homeostasis have received the first genetic signature as recently as 2012. These disorders, predominantly...

Cite
Kapoor D, Garg D, Sharma S, et al. Inherited Manganese Disorders and the Brain: What Neurologists Need to Know. Ann Indian Acad Neurol. 2021;24(1):15-21doi: 10.4103/aian.AIAN_789_20.
Kapoor, D., Garg, D., Sharma, S., & Goyal, V. (2021). Inherited Manganese Disorders and the Brain: What Neurologists Need to Know. Annals of Indian Academy of Neurology, 24(1), 15-21. https://doi.org/10.4103/aian.AIAN_789_20
Kapoor, Dipti, et al. "Inherited Manganese Disorders and the Brain: What Neurologists Need to Know." Annals of Indian Academy of Neurology vol. 24,1 (2021): 15-21. doi: https://doi.org/10.4103/aian.AIAN_789_20
Kapoor D, Garg D, Sharma S, Goyal V. Inherited Manganese Disorders and the Brain: What Neurologists Need to Know. Ann Indian Acad Neurol. 2021 Jan-Feb;24(1):15-21. doi: 10.4103/aian.AIAN_789_20. Epub 2021 Feb 05. PMID: 33911374; PMCID: PMC8061520.
Copy Download .nbib Format: NLM
Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity.

Bioelectricity

Jones TH, Kaul K, Garg AA, Song JW, Ganju RK, Subramaniam VV.
PMID: 34476380
Bioelectricity. 2021 Mar 01;3(1):92-100. doi: 10.1089/bioe.2020.0048. Epub 2021 Mar 16.

No abstract available.

Cite
Jones TH, Kaul K, Garg AA, et al. Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity. Bioelectricity. 2021;3(1):92-100doi: 10.1089/bioe.2020.0048.
Jones, T. H., Kaul, K., Garg, A. A., Song, J. W., Ganju, R. K., & Subramaniam, V. V. (2021). Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity. Bioelectricity, 3(1), 92-100. https://doi.org/10.1089/bioe.2020.0048
Jones, Travis H, et al. "Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity." Bioelectricity vol. 3,1 (2021): 92-100. doi: https://doi.org/10.1089/bioe.2020.0048
Jones TH, Kaul K, Garg AA, Song JW, Ganju RK, Subramaniam VV. Directional Migration of Breast Cancer Cells Hindered by Induced Electric Fields May Be Due to Accompanying Alteration of Metabolic Activity. Bioelectricity. 2021 Mar 01;3(1):92-100. doi: 10.1089/bioe.2020.0048. Epub 2021 Mar 16. PMID: 34476380; PMCID: PMC8370484.
Copy Download .nbib Format: NLM
Efficacy of signal peptide predictors in identifying signal peptides in the experimental secretome of Picrophilous torridus, a thermoacidophilic archaeon.

PloS one

Singhal N, Garg A, Singh N, Gulati P, Kumar M, Goel M.
PMID: 34358261
PLoS One. 2021 Aug 06;16(8):e0255826. doi: 10.1371/journal.pone.0255826. eCollection 2021.

Secretory proteins are important for microbial adaptation and survival in a particular environment. Till date, experimental secretomes have been reported for a few archaea. In this study, we have identified the experimental secretome of Picrophilous torridus and evaluated the...

Cite
Singhal N, Garg A, Singh N, et al. Efficacy of signal peptide predictors in identifying signal peptides in the experimental secretome of Picrophilous torridus, a thermoacidophilic archaeon. PLoS One. 2021;16(8):e0255826doi: 10.1371/journal.pone.0255826.
Singhal, N., Garg, A., Singh, N., Gulati, P., Kumar, M., & Goel, M. (2021). Efficacy of signal peptide predictors in identifying signal peptides in the experimental secretome of Picrophilous torridus, a thermoacidophilic archaeon. PloS one, 16(8), e0255826. https://doi.org/10.1371/journal.pone.0255826
Singhal, Neelja, et al. "Efficacy of signal peptide predictors in identifying signal peptides in the experimental secretome of Picrophilous torridus, a thermoacidophilic archaeon." PloS one vol. 16,8 (2021): e0255826. doi: https://doi.org/10.1371/journal.pone.0255826
Singhal N, Garg A, Singh N, Gulati P, Kumar M, Goel M. Efficacy of signal peptide predictors in identifying signal peptides in the experimental secretome of Picrophilous torridus, a thermoacidophilic archaeon. PLoS One. 2021 Aug 06;16(8):e0255826. doi: 10.1371/journal.pone.0255826. eCollection 2021. PMID: 34358261; PMCID: PMC8345856.
Copy Download .nbib Format: NLM
Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.

JAMA pediatrics

Ramaswamy VV, Bandyopadhyay T, Nanda D, Bandiya P, Ahmed J, Garg A, Roehr CC, Nangia S.
PMID: 33720274
JAMA Pediatr. 2021 Jun 01;175(6):e206826. doi: 10.1001/jamapediatrics.2020.6826. Epub 2021 Jun 07.

IMPORTANCE: The safety of postnatal corticosteroids used for prevention of bronchopulmonary dysplasia (BPD) in preterm neonates is a controversial matter, and a risk-benefit balance needs to be struck.OBJECTIVE: To evaluate 14 corticosteroid regimens used to prevent BPD: moderately early-initiated,...

Cite
Ramaswamy VV, Bandyopadhyay T, Nanda D, et al. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis. JAMA Pediatr. 2021;175(6):e206826doi: 10.1001/jamapediatrics.2020.6826.
Ramaswamy, V. V., Bandyopadhyay, T., Nanda, D., Bandiya, P., Ahmed, J., Garg, A., Roehr, C. C., & Nangia, S. (2021). Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis. JAMA pediatrics, 175(6), e206826. https://doi.org/10.1001/jamapediatrics.2020.6826
Ramaswamy, Viraraghavan Vadakkencherry, et al. "Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis." JAMA pediatrics vol. 175,6 (2021): e206826. doi: https://doi.org/10.1001/jamapediatrics.2020.6826
Ramaswamy VV, Bandyopadhyay T, Nanda D, Bandiya P, Ahmed J, Garg A, Roehr CC, Nangia S. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis. JAMA Pediatr. 2021 Jun 01;175(6):e206826. doi: 10.1001/jamapediatrics.2020.6826. Epub 2021 Jun 07. PMID: 33720274; PMCID: PMC7961472.
Copy Download .nbib Format: NLM
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.

Clinical cancer research : an official journal of the American Association for Cancer Research

Xing L, Wang S, Liu J, Yu T, Chen H, Wen K, Li Y, Lin L, Hsieh PA, Cho SF, An G, Qiu L, Kinneer K, Munshi N, Anderson KC, Tai YT.
PMID: 34301753
Clin Cancer Res. 2021 Jul 23; doi: 10.1158/1078-0432.CCR-21-1621. Epub 2021 Jul 23.

PURPOSE: Efforts are required to improve the potency and durability of CD38- and BCMA-based immunotherapies in human multiple myeloma. We here delineated the molecular and cellular mechanisms underlying novel immunomodulatory effects triggered by BCMA pyrrolobenzodiazepine (PBD) antibody drug conjugate...

Cite
Xing L, Wang S, Liu J, et al. BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1621.
Xing, L., Wang, S., Liu, J., Yu, T., Chen, H., Wen, K., Li, Y., Lin, L., Hsieh, P. A., Cho, S. F., An, G., Qiu, L., Kinneer, K., Munshi, N., Anderson, K. C., & Tai, Y. T. (2021). BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1621
Xing, Lijie, et al. "BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1621
Xing L, Wang S, Liu J, Yu T, Chen H, Wen K, Li Y, Lin L, Hsieh PA, Cho SF, An G, Qiu L, Kinneer K, Munshi N, Anderson KC, Tai YT. BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clin Cancer Res. 2021 Jul 23; doi: 10.1158/1078-0432.CCR-21-1621. Epub 2021 Jul 23. PMID: 34301753.
Copy Download .nbib Format: NLM
Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report.

Journal of medical cases

Garg A, Goli H, Yazdanpanah F.
PMID: 34429795
J Med Cases. 2021 Jun;12(6):226-229. doi: 10.14740/jmc3674. Epub 2021 Mar 24.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that has caused a pandemic across the world in the years 2019 - 2020 with over 100 countries reporting high infection rates. The virus is unique in the...

Cite
Garg A, Goli H, Yazdanpanah F. Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report. J Med Cases. 2021;12(6):226-229doi: 10.14740/jmc3674.
Garg, A., Goli, H., & Yazdanpanah, F. (2021). Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report. Journal of medical cases, 12(6), 226-229. https://doi.org/10.14740/jmc3674
Garg, Akash, et al. "Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report." Journal of medical cases vol. 12,6 (2021): 226-229. doi: https://doi.org/10.14740/jmc3674
Garg A, Goli H, Yazdanpanah F. Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report. J Med Cases. 2021 Jun;12(6):226-229. doi: 10.14740/jmc3674. Epub 2021 Mar 24. PMID: 34429795; PMCID: PMC8279281.
Copy Download .nbib Format: NLM
Showing 1081 to 1088 of 1088 entries